Patent details

Basic Information

Publication number:

EP2890687

PCT Application Number:

IB2013058109

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138120753

PCT Publication Number:

WO2014033654

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SALTS OF BENZOTHIAZOLONE COMPOUND AS BETA-2-ADRENOCEPTOR AGONIST

French Title of Invention:

SELS DE COMPOSÉ BENZOTHIAZOLONE UTILISÉS EN TANT QU'AGONISTE DE BETA-2-ADRENOCEPTOR

German Title of Invention:

SALZE EINER BENZOTHIAZOLONVERBINDUNG ALS BETA-2-ADRENOZEPTORAGONIST

SPC Number:

Dates

Filing date:

29/08/2013

Grant date:

28/06/2017

EP Publication Date:

08/07/2015

PCT Publication Date:

06/03/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/06/2017

EP B1 Publication Date:

28/06/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/08/2019

Expiration date:

29/08/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/06/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

TUFILLI, Nicola

Address:

Switzerland (CH)

2

Name:

GRANDEURY, Arnaud

Address:

Switzerland (CH)

Priority

Priority Number:

2392012

Priority Date:

30/08/2012

Priority Country:

Iraq (IQ)

Classification

IPC classification:

A61K 31/428; A61P 21/00; C07D 277/68;

Publication

European Patent Bulletin

Issue number:

201726

Publication date:

28/06/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/08/2018

Last Annual Fee Paid Number:

6

Last Annual Fee Paid Amount:

66 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages